Cytodyn Inc (CYDY)

[Saltz]

Exactly.

All these new investors will be pleased to discover Covid-19 is the tip of the spear. The meat is HIV, mTNBC, and 20 plus additional cancer indications, with HIV drug approval expected later
this year.

It’s a huge advantage to get into a Covid-19 play with so much promise. A free insurance policy with CYDY’s valuation substantially North of $3 even when Covid-19 is subtracted from the mix.

Leronlimab is going to deliver consistently by saving lives and taking very sick patients off ventilators. What’s that worth? These very sick patients that are on ventilators exhausted the big two options - Hydroxychloroquine and Remdesivir to no avail. If Leronlimab can bring that type of patient back to health what can it do earlier in the progression of Covid-19?

That is one of many questions that will be answered a day at a time. The results and data just continue to stack. The tipping point is approaching. Place your bets.